Inhibition of phosphodiesterase10A attenuates morphine-induced conditioned place preference

Molecular Brain

Volumn 7, Issue 1, 2014, Pages

  Mu, Ying ^a   Ren, Zhaoxiang ^a   Jia, Jia ^a   Gao, Bo ^a   Zheng, Longtai ^a   Wang, Guanghui ^a   Friedman, Eitan ^b   Zhen, Xuechu ^a  

^a SOOCHOW UNIVERSITY   (China)

^b CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

cAMP response element binding protein; Conditional place preference; Delta FosB; Morphine; Nucleus accumbens; Phosphodiesterase10A; Striatum

Indexed keywords

2 [4 [1 METHYL 4 (4 PYRIDINYL) 3 PYRAZOLYL]PHENOXYMETHYL]QUINOLINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MORPHINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE 10A; PHOSPHOPROTEIN; TRANSCRIPTION FACTOR DELTA FOSB; UNCLASSIFIED DRUG; FOSB PROTEIN, RAT; PDE10A PROTEIN, RAT; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR CINGULATE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORPUS STRIATUM; DORSOMEDIAL STRIATUM; DOSE RESPONSE; DRUG DEPENDENCE TREATMENT; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME INHIBITION; LOW DRUG DOSE; MALE; MORPHINE ADDICTION; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REINFORCEMENT; ANIMAL; CONDITIONING; DECISION MAKING; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

ANIMALS; CHOICE BEHAVIOR; CONDITIONING (PSYCHOLOGY); CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; MALE; MORPHINE; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; RATS, SPRAGUE-DAWLEY;

EID: 84908126352     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/s13041-014-0070-1     Document Type: Article

References (40)

1. Shoblock JR, Wichmann J, Maidment NT: The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference. Neuropharmacology 2005, 49:439-446.
2. Aguilar MA, Rodríguez-Arias M, Miñarro J: Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 2009, 59:253-277.
3. Tzschentke TM: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007, 12:227-462.
4. Mueller D, Perdikaris D, Stewart J: Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference. Behav Brain Res 2002, 136:389-397.
5. Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J: NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference. Brain Res Bull 2005, 64:493-503.
6. Wei XL, Su RB, Lu XQ, Liu Y, Yu SZ, Yuan BL, Li J: Inhibition by agmatine on morphine-induced conditioned place preference in rats. Eur J Pharmacol 2005, 515:99-106.
7. Xie Z, Adamowicz WO, Eldred WD, Jakowski AB, Kleiman RJ, Morton DG, Stephenson DT, Strick CA, Williams RD, Menniti FS: Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase. Neuroscience 2006, 139:597-607.
8. Seeger TF, Bartlett B, Coskran TM, Culp JS, James LC, Krull DL, Lanfear J, Ryan AM, Schmidt CJ, Strick CA, Varghese AH, Williams RD, Wylie PG, Menniti FS: Immunohistochemical localization of PDE10A in the rat brain. Brain Res 2003, 985:113-126.
9. Humphries MD, Prescott TJ: The ventral basal ganglia, a selection mechanism at the crossroads of space, strategy, and reward. Prog Neurobiol 2010, 90:385-417.
10. Hebb AL, Robertson HA, Denovan-Wright EM: Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice. Eur Neuropsychopharmacol 2008, 18:339-363.
11. Schmidt CJ, Chapin DS, Cianfrogna J, Corman ML, Hajos M, Harms JF, Hoffman WE, Lebel LA, McCarthy SA, Nelson FR, Proulx-LaFrance C, Majchrzak MJ, Ramirez AD, Schmidt K, Seymour PA, Siuciak JA, Tingley FD 3rd, Williams RD, Verhoest PR, Menniti FS: Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. J Pharmacol Exp Ther 2008, 325:681-690.
12. Cador M, Bjijou Y, Cailhol S, Stinus L: D-amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience 1999, 94:705-721.
13. Robison AJ, Nestler EJ: Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 2011, 12:623-637.
14. Ma YY, Meng L, Guo CY, Han JS, Lee DY, Cui CL: Dose- and time-dependent, context-induced elevation of dopamine and its metabolites in the nucleus accumbens of morphine-induced CPP rats. Behav Brain Res 2009, 204:192-199.
15. Zhang D, Zhang H, Jin GZ, Zhang K, Zhen X: Single dose of morphine produced a prolonged effect on dopamine neuron activities. Mol Pain 2008, 4:57.
16. Nakagawa T, Suzuki Y, Nagayasu K, Kitaichi M, Shirakawa H, Kaneko S: Repeated exposure to methamphetamine, cocaine or morphine induces augmentation of dopamine release in rat mesocorticolimbic slice co-cultures. PLoS One 2011, 6:e24865.
17. Sanchez CJ, Bailie TM, Wu WR, Li N, Sorg BA: Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience 2003, 119:497-505.
18. Thompson BE, Sachs BD, Kantak KM, Cherry JA: The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice. Eur J Neurosci 2004, 19:2561-2568.
19. Kam AY, Liao D, Loh HH, Law PY: Morphine induces AMPA receptor internalization in primary hippocampal neurons via calcineurin-dependent dephosphorylation of GluR1 subunits. J Neurosci 2010, 30:15304-15316.
20. Briand LA, Blendy JA: Molecular and genetic substrates linking stress and addiction. Brain Res 2010, 1314:219-234.
21. CarlezonWA Jr, Duman RS, Nestler EJ: The many faces of CREB. Trends Neurosci 2005, 28:436-445.
22. Moron JA, Gullapalli S, Taylor C, Gupta A, Gomes I, Devi LA: Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology 2010, 35:955-966.
23. Nestler EJ, Barrot M, Self DW: DeltaFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci U S A 2001, 98:11042-11046.
24. Sim-Selley LJ, Cassidy MP, Sparta A, Zachariou V, Nestler EJ, Selley DE: Effect of DeltaFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens. Neuropharmacology 2011, 61:1470-1476.
25. Nestler EJ: Molecular mechanisms of drug addiction. Neuropharmacology 2004, 47(Suppl 1):24-32.
26. McDaid J, Dallimore JE, Mackie AR, Napier TC: Changes in accumbal and pallidal pCREB and deltaFosB in morphine-sensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum. Neuropsychopharmacology 2006, 6:1212-1226.
27. Grauer SM, Pulito VL, Navarra RL, Kelly MP, Kelley C, Graf R, Langen B, Logue S, Brennan J, Jiang L, Charych E, Egerland U, Liu F, Marquis KL, Malamas M, Hage T, Comery TA, Brandon NJ: Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenias. J Pharmacol Exp Ther 2009, 331:574-590.
28. McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ: DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res 2004, 132:146-154.
29. Barrot M, Olivier JD, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ, Impey S, Storm DR, Neve RL, Yin JC, Zachariou V, Nestler EJ: CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci U S A 2002, 99:11435-11440.
30. Harlan RE, Kailas SR, Tagoe CE, Garcia MM: Morphine actions in the rat forebrain: role of protein kinase C. Brain Res Bull 2004, 62:285-295.
31. Manzanedo C, Aguilar MA, Rodriguez-Arias M, Minarro J: Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav Brain Res 2001, 121:189-197.
32. Nunez C, Gonzalez-Cuello A, Sanchez L, Vargas ML, Milanes MV, Laorden ML: Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus. Eur J Pharmacol 2009, 620:1-8.
33. Liddie S, Anderson KL, Paz A, Itzhak Y: The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice. J Psychopharmacol 2012, 26:1375-1382.
34. Crawford CA, Villafranca SW, Cyr MC, Farley CM, Reichel CM, Gheorghe SL, Krall CM, McDougall SA: Effects of early methylphenidate exposure on morphine- and sucrose-reinforced behaviors in adult rats: relationship to dopamine D2 receptors. Brain Res 2007, 1139:245-253.
35. Taracha E, Chrapusta SJ, Lehner M, Skorzewska A, Maciejak P, Szyndler J, Plaznik A: Morphine and methadone pre-exposures differently modify brain regional Fos protein expression and locomotor activity responses to morphine challenge in the rat. Drug Alcohol Depend 2008, 97:21-32.
36. Philibin SD, Hernandez A, Self DW, Bibb JA: Striatal signal transduction and drug addiction. Front Neuroanat 2011, 5:60.
37. Sotty F, Montezinho LP, Steiniger-Brach B, Nielsen J: Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons. J Neurochem 2009, 109:766-775.
38. Brunzell DH, Mineur YS, Neve RL, Picciotto MR: Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference. Neuropsychopharmacology 2009, 34:1993-2001.
39. Chauvet C, Lardeux V, Jaber M, Solinas M: Brain regions associated with the reversal of cocaine conditioned place preference by environmental enrichment. Neuroscience 2011, 184:88-96.
40. Chartoff EH, Barhight MF, Mague SD, Sawyer AM, Carlezon WA Jr: Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats. Psychopharmacology (Berl) 2009, 204:227-239.